Camena Bioscience closes $10m Series A financing as demand for DNA synthesis technology increases
Camena has also strengthened the Board of Directors with key appointments
11-Jul-2023 -
Camena Bioscience, a synthetic biology company providing genes to the pharmaceutical and biotechnology industries, announced it has closed a $10m Series A financing round, led by Mercia. The new funding will be used to scale operations and continue development of its pioneering DNA synthesis ...
DNA synthesis
financing
Series A financing
+1